The global sports
medicine market was valued at approximately $6.1 billion in
2024 and is expected to grow at a rate of ~8% during the forecast period. The
growing cases of sports injuries, technological advancements and new product
innovations in sports medicine, rising demand for minimally invasive surgeries,
development in regenerative medicine, and an increasing awareness of the
importance of physical fitness and sports activities are some of the key
factors driving the market growth.
Sports medicine is an umbrella term representing
a broad array of specialties that bridges the academic disciplines of medicine
and physical education as well as the basic sciences. It also entails the
treatment of damage to bone, cartilage, and tissue through minimally invasive
procedures. The procedures, often in the knee, hip, and shoulder, allow
patients to quickly return to their active lifestyles.
Download a free sample report now 👉
https://meditechinsights.com/sports-medicine-market/request-sample/
Potential of sports medicines to treat sports injuries
boosts market growth
Sporting injuries are inevitable for anyone who actively
engages in physical activity. People of all ages are more active than ever
before and whenever they seek treatment for an injury or a degenerative
condition, they expect a fast recovery and rapid return to activity.
Development in regenerative medicine in the sporting arena focuses
predominantly on cartilage, tendon, ligament, meniscal, and skeletal muscle
injuries. One such development in regenerative medicine, which is gaining
traction for its minimally invasive approach and regenerative potential, is
incorporating stem cell-based treatments in sports medicine, specifically
mesenchymal stem cells (MSCs), which are currently under clinical trials for
their ability to expedite healing in tendon and cartilage injuries. For
instance, in January 2024, Smith+Nephew announced that it had completed the
acquisition of CartiHeal, developer of Agili-C, a novel sports medicine
technology for cartilage regeneration in the knee.
Technological advancements in the orthopedic field such as
the 3D printing of implants and the introduction of bionic technology, and
sensor technology in prosthetic limbs offer unprecedented growth opportunities.
The future shows a trend toward prevention through genetics, nutrigenomics, and
numerous monitors and wearables in sports medicine, which is further expected
to drive the market during the forecast period.
Increasing emphasis on developing new advanced sports
medicine products
The field of sports medicine encompasses a wide variety of
disciplines, from orthopedics and physiotherapy to psychiatry and public
health. There have been many recent advances in the products category of sports
medicine, such as rotator cuff repair, anterior cruciate ligament
reconstruction, high altitude simulation training, anti-gravity treadmill,
exoskeletons, bio-harnesses, smart fabrics, virtual and augmented reality and
hip/knee arthroscopy that are revolutionizing the global sports medicine market.
For instance,
- In
January 2023, Arthrex, announced its ACL TightRope implant has received
FDA approval for pediatric indications. The anterior cruciate ligament
(ACL) injuries are common among young athletes and the TightRope implant
is used for the surgical treatment these injuries
- In
November 2022, Smith+Nephew announced the introduction of its
JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total
knee arthroplasty. This new procedural product solution aims to provide
surgeons with the clinical advantage of advanced bearing material and
anatomic design combined with the efficiency and potential long-term tibia
fixation of a cementless knee
- In
March 2022, DePuy Synthes, the Orthopaedics Company of Johnson &
Johnson, announced the addition of two innovations to its kinematically
advanced and proven ATTUNE Knee portfolio: the ATTUNE Cementless Fixed
Bearing Knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized
Knee System.
Rising incidence of youth sports injuries fuels the
global sports medicine market
More than 3.5 million children under the age 14 receive
medical treatment for sports injuries each year. Young athletes, especially
those younger than 8 are more prone to sports injuries than adults due to
ongoing growth spurts, slower reaction times, and still-developing hand-eye
coordination. Injuries to the face or head are more common and account for 27%
of high school sports injuries. Also, more than 775,000 children, ages 14 and
younger, are treated in hospital emergency rooms for sports-related injuries
each year.
Competitive Landscape Analysis
The global sports medicine market is marked by the presence
of established and emerging market players such as Arthrex Inc.;
Smith & Nephew Plc.; DePuy Synthes (Johnson & Johnson MedTech); Stryker
Corporation; CONMED Corporation; Zimmer Biomet Holdings Inc; KARL STORZ;
IntraVu; Mueller Sports Medicine; and Orthofix International N.V. among
others. Some of the key strategies adopted by market players include new
product development, strategic partnerships and collaborations, and geographic
expansion.
Organic and Inorganic Growth Strategies Adopted by
Leading Players to Establish Their Foothold in the Sports Medicine Market
All key players operating in the sports medicine market are
adopting both organic and inorganic growth strategies such as collaborations,
acquisitions, and new product launches to garner a higher market share.
For instance,
- In
November 2024, Johnson & Johnson MedTech signed an exclusive
commercial distribution agreement with Responsive Arthroscopy Inc., which
will strengthen its sports platform and meet the rising demand of the
rapidly growing sports soft tissue repair market
- In
August 2024, Zimmer Biomet Holdings, Inc. announced that it signed a
definitive agreement to acquire OrthoGrid Systems, Inc. The acquisition
will expand Zimmer Biomet's portfolio, which will now have OrthoGrid's
AI-powered, fluoroscopy-based surgical assistance platform, Hip AI, as
well as two additional FDA-cleared orthopedic applications and over 40
patents
- In
July 2024, Stryker completed the acquisition of Artelon, specializing
in innovative soft tissue fixation products for foot and ankle and sports
medicine procedures
The sports medicine market is a growing market and is
expected to gain further momentum in the upcoming years due to a strong
emphasis on developing new minimally invasive products, investment in R&D
to introduce several advanced products, increasing awareness regarding fitness
regimes and sports activities, and aggressive organic and inorganic growth
strategies followed by the market players.
Global Sports Medicine Market Segmentation
This report by Medi-Tech Insights provides the size of
the global sports medicine market at the regional- and country-level from
2023 to 2030. The report further segments the market based on product,
application, and end-user.
Download a sample report for in-depth competitive
insights
https://meditechinsights.com/sports-medicine-market/request-sample/
Market Size & Forecast (2023-2030), By Product, USD
Million
- Body
Reconstruction
- Surgical
Equipment
- Soft
Tissue Repair
- Bone
Reconstruction Devices
- Body
Support & Recovery
- Braces
and Other Support Devices
- Compression
Clothing
- Hot
& Cold Therapy
- Body
Monitoring & Evaluation
- Accessories
- Bandages
- Tapes
- Disinfectants
- Wraps
- Other
Market Size & Forecast (2023-2030), By Application,
USD Million
- Knee
- Shoulder
- Ankle
& Foot
- Hip
- Spine
Injuries
Market Size & Forecast (2023-2030), By End-user, USD
Million
- Hospitals
- Ambulatory
Surgical Centers
- Physiotherapy
Clinics
- Others
Market Size & Forecast (2023-2030), By Region, USD
Million
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
About
Medi-Tech Insights
Medi-Tech
Insights is a healthcare-focused business research & insights firm. Our
clients include Fortune 500 companies, blue-chip investors & hyper-growth
start-ups. We have completed 100+ projects in Digital Health, Healthcare IT,
Medical Technology, Medical Devices & Pharma Services in the areas of
market assessments, due diligence, competitive intelligence, market sizing and
forecasting, pricing analysis & go-to-market strategy. Our methodology
includes rigorous secondary research combined with deep-dive interviews with
industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment